Strand Therapeutics Announces Poster Presentation on STX-001 at the 2023 AACR Annual Meeting

On March 14, 2023 Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, reported the details of its poster presentation at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023, being held from April 14 – 19, 2023 in Orlando, Florida (Press release, Strand Therapeutics, MAR 14, 2023, View Source [SID1234628734]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Strand will present preclinical data from its lead programmable mRNA candidate STX-001, a multi-modal synthetic self-replicating mRNA technology that delivers a prolonged and locally-acting IL-12 cytokine to the tumor microenvironment. STX-001, when delivered directly to the tumor, induces a highly immunogenic tumor cell death while the mRNA-encoded IL-12 payload promotes recruitment of effector T cells and NK cells into the tumor microenvironment.

Details of the presentation are as follows:

Presentation Title: STX-001, a locally administered LNP-formulated self-replicating mRNA that encodes the therapeutic payload IL-12, induces deep systemic immune responses to solid tumors

Session Category: Experimental and Molecular Therapeutics

Session Title: Gene and Vector-based Therapy

Session Date and Time: Monday Apr 17, 1:30 PM – 5:00 PM ET

Location: Orange County Convention Center, Orlando, Florida, Poster Section 16

Poster Board Number: 2

Permanent Abstract Number: 2731

The full text of the abstract will be published to the AACR (Free AACR Whitepaper) Online Program Planner at 4:30 PM ET on Tuesday, March 14. The abstract will also be published in an online-only supplement to the AACR (Free AACR Whitepaper) journal Cancer Research on Friday, March 31. Additional meeting information is available on the AACR (Free AACR Whitepaper) website.